Pharmacognostical and Pharmaceutical Analysis of Amavatari Rasa: A Herbo-mineral Compound
DOI:
https://doi.org/10.37591/(rrjops).v7i2.491Abstract
Amavatari Rasa is a herbo-mineral formulation, composed of processed mercury, sulphar, Terminalia chebula Retz, Terminalia bellerica Roxb., Phyllanthus embilica (Embelica officinalis Gaertn), Plambagozeylenica Linn., Commiphora wightii (Arn) Bhand and Ricinuscommunis Linn. This formulation is routinely practiced in cases of Rheumatoid Arthritis, but preliminary physicochemical and pharmacognostical profiles are not available. Considering this, an attempt has been made to develop this profile. Pharmacognostical study of raw drugs was carried out. Organoleptic features of fine powder made out of crude drugs were within the standard range. Loss on drying (LOD) was 0.5% w/w, total ash14.5% w/w, acid insoluble ash3.5%w/w and pH 6.5 was obtained as a result of analytical studies. High Performance Thin Layer Chromatography (HPTLC) showed difference of results when the sample scanned at two wave lengths i.e., 254 nm and 366 nm having 14 and 12 spots respectively. This shows presence of certain constituents in the powder and is helpful for the easy separation of these constituents. All above parameters helps to prepare the finger printing of classical drug Amavatari Rasa.
Keywords: Amavatari Rasa, Rheumatoid Arthritis, HPTLC, Pharmacognostical study, Amalaki
Cite this Article
Sonam S. Bhinde, P.K. Prajapati, Galib, Harisha C.R, VJ Shukla. Pharmacognostical and Pharmaceutical Analysis of Amavatari Rasa: A Herbo-mineral Compound. Research and Reviews: A Journal of Pharmaceutical Science. 2016; 7(2): 6–10p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |